Primary Care

No evidence of benefit for insulin analogs over nph insulin

No evidence of benefit for insulin analogs over nph insulin

Tujeo and Tresiba are two new long-acting insulin analogs that can be prescribed to patients with type 1 and type 2 diabetes to maintain normal blood glucose levels between meals and at night. Patients with type 1 diabetes should combine this type of insulin with the insulin recommended for administration at meals – most often …

No evidence of benefit for insulin analogs over nph insulin Read More »

No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes

No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes

Research question: In people with type 2 diabetes inadequately controlled with metformin, which additional oral therapy offers the greatest improvement in HbA1c? The reviewers just looked at glycaemic control in patients whose starting HbA1c was 7% or higher at 12 weeks or longer follow-up. The evidence: Eight randomised trials were found, which looked at various …

No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes Read More »

effectiveness of peer support in type 2 diabetes

More evidence needed on the cost effectiveness of peer support in type 2 diabetes

The modern world offers our society a global acceleration of life. Day after day passes, people build a career, live an active social life, and periodically struggle with emerging problems and diseases. In this rhythm, it is impossible not to pay attention to the fact that the younger generation often remains left to themselves. Of …

More evidence needed on the cost effectiveness of peer support in type 2 diabetes Read More »

https://www.thediabeteself.net/populations-and-settings/primary-care/metformin-may-be-associated-with-a-reduced-risk-of-liver-cancer-in-type-2-diabetes/

Metformin may reduce the risk of cancer but more research is needed

The drug, which is used to treat diabetes, can provoke the development of cancer, – reports the Polish publication Dziennik Dziennik Gazeta Prawna. We are talking about Metformin, which, as stated in the publication, may contain a toxic chemical compound – it provokes the development of cancer. The facts of” contamination ” of the drug …

Metformin may reduce the risk of cancer but more research is needed Read More »

Metformin

Metformin may be associated with a reduced risk of liver cancer in type 2 diabetes

Effectiveness and features of Metformin administration in diabetes mellitus OUR READERS RECOMMEND! . Seeing the popularity of this tool, we decided to offer it to your attention. Metformin is a vital drug for people with diabetes. The drug has a glucose-lowering effect that regulates blood sugar levels, reduces appetite and promotes active fat burning. The …

Metformin may be associated with a reduced risk of liver cancer in type 2 diabetes Read More »